SCHEMBL30879277

SCHEMBL30879277

CN1CCN(c2ccc(N)cc2OCCC2CCCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.50
MAPT P10636 5/20 0.47
KDM4E B2RXH2 3/20 0.47
RAD52 P43351 2/20 0.47
HRH4 Q9H3N8 2/20 0.41
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 4/20 0.40
ADRA2C P18825 3/20 0.40
PTK2B Q14289 3/20 0.40
KMT2A Q03164 2/20 0.40
GFER P55789 2/20 0.40
ESR2 Q92731 1/20 0.40
ACHE P22303 1/20 0.39
HTR4 Q13639 1/20 0.39
DRD2 P14416 3/20 0.39
HTR2A P28223 2/20 0.39
MCHR1 Q99705 1/20 0.39
POLB P06746 1/20 0.38
HTT P42858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878933 0.99 NFE2L2 (0.52) NFE2L2MAPTKDM4ERAD52HRH4
SCHEMBL30879025 0.94 MAPT (0.46) NFE2L2MAPTKDM4ERAD52HRH4
SCHEMBL30878657 0.88 MAPT (0.49) MAPTKDM4ERAD52HRH4ALDH1A1
SCHEMBL30879147 0.82 MAPT (0.54) MAPTKDM4ERAD52ALDH1A1L3MBTL1
SCHEMBL30310838 0.81 MAPT (0.41) MAPTKDM4ERAD52ALDH1A1L3MBTL1
SCHEMBL30019224 0.81 MAPT (0.52) MAPTKDM4ERAD52HRH4ALDH1A1
SCHEMBL30879346 0.81 CYP19A1 (0.45) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL30879090 0.80 CYP19A1 (0.47) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL25565665 0.79 MAPT (0.56) MAPTKDM4ERAD52ALDH1A1L3MBTL1
SCHEMBL30879012 0.79 MAPT (0.50) MAPTKDM4ERAD52HRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed